Arrowhead Pharmaceuticals Presents Plozasiran Data on Renal and Hepatic Impairment Yardeni Suggests Fed Could Raise Rates in July to Counter Bond Vigilantes Amid Warsh Transition Northeast Region Consumer Price Index Data Released for April 2026 DeEscalation Headlines Pressure Gold Prices as Memorial Day Weekend Approaches Rubio Assures NATO Allies as Trump Reverses Course on Poland Troop Deployment European Stocks Hit Highest Since March 2 as USIran Talks Continue Euro Zone Bond Yields Fall on Peace Hopes Essent Group Ltd ESNT Q1 2026 Earnings Strong EPS Beat Amidst Market Headwinds Cass Information Systems Q1 2026 Earnings EPS Beat by Nearly 6 but Stock Slips on Missing Revenue Details NCSM Q1 2026 Earnings Significant EPS Miss Amid Challenging Market Conditions BHFAP Q1 2026 Earnings EPS Misses Estimates Shares Edge Lower NVS Q1 2026 Earnings EPS Falls Short by 85 But Stock Holds Steady STTK Q1 2026 Earnings Narrower Loss Surprises No Revenue as Pipeline Progress Continues Kornit Digital Shares Drop Nearly 5 as Selling Pressure Mounts Tiptree Inc TIPT Edges Lower Amid Cautious Trading Key Levels in Focus CNA Financial CNA Edges Higher as Shares Stabilize Near Support Levels Cohu Inc COHU Rallies Over 5 as Semiconductor Equipment Demand Trends Improve MercadoLibre MELI Slides Slightly Amid Broader Market Pressures Key Levels to Watch Kiplinger Highlights Key Earnings Reports for May 2529 Week OWLT Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Surprise Despite Stock Decline IPDN Slips 56 as MicroCap Stock Tests Support Near 061 Galata Acquisition Corp II LATA Holds Steady Near 1005 SPAC Trading in Neutral Territory Millennium Group International MGIH Edges Lower Amidst Consolidation Near Key Support WVVIP Preferred Shares Slide 34 as Support Levels Approach ClearThink 1 Acquisition Corp Units CTAAU Hold Steady at 1006 Stability in a Quiet SPAC Market Jefferies Financial Group JEF Holds Steady Near 5256 as Support and Resistance Define Trading Range Mexico Fund Inc MXF Surges 175 Above Support Testing Key Resistance at 2318 CRISPR Therapeutics Consolidates Near Support as Gene Editing Sector Awaits Catalysts